Skip to content

The Role of NEMS for Post ICU Rehabilitation

The Role of Neuromuscular Electrical Stimulation as a Tool for Post ICU Rehabilitation

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01717833
Enrollment
120
Registered
2012-10-31
Start date
2010-11-30
Completion date
2015-12-31
Last updated
2015-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

ICU acquired weakness, Critical illness polyneuromyopathy, post ICU rehabilitation, neuromuscular electrical rehabilitation, handgrip

Brief summary

The purpose of this study is to investigate the role of NEMS as a rehabilitation tool for muscle weakness following critical illness. The investigators hypothesized that NEMS combined with exercise rehabilitation will have a beneficial role in restoration of muscle strength

Detailed description

Survivors of critical illness are presented with significant physical impairment that is associated with reduced functional ability and health -related quality of life both in the short and long-term. Neuromuscular electrical stimulation (NEMS) has been proposed as an alternative exercise modality in patients with severe chronic obstructive pulmonary disease and chronic heart failure, who cannot perform active exercise. NEMS has also been used as a preventive tool for intensive care unit (ICU) acquired weakness (ICUAW). Its role as a tool for post ICU rehabilitation has not been evaluated so far. A randomized intervention study was designed to assess the efficacy of NEMS, as a rehabilitative tool for critical illness survivors. The first day that patients are discharged from the ICU after stratified randomization are assigned to the NEMS group or to the control group. In the NEMS group, NEMS will be applied to both lower extremities of the NEMS -group simultaneously (quadriceps femoris muscle and peroneus longus) on a daily basis, along with a personalized exercise program. NEMS sessions will continue until patient discharge from hospital. In the control group, sham NEMS will be applied along with standard care when it comes to physiotherapy. At hospital discharge patients of both groups of will receive a rehabilitation booklet. Patients on the NEMS group that have significant muscle weakness will have NEMS sessions at home for a period of 2 months. Patients are evaluated at 3 and 6 months after hospital discharge

Interventions

PROCEDURENEMS

NEMS sessions on both lower extremities (quadriceps and peroneus longus) simultaneously

PROCEDURESham

Sham sessions of neuromuscular electrical stimulation

Sponsors

University of Athens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients under mechanical ventilation for\> 72hours during ICU stay * Patients able to perform simple commands (able to be evaluated by MRC scale)

Exclusion criteria

* age \< 18 \> 85 years * pregnancy * pre-existing neuromuscular disease (e.g. Gravis) * fractures or skin lesions that do not allow the implementation of NEMS * presence of pacemaker or defibrillator * fractures of spine that so not allow mobilization * BMI \> 35 kg/m2 * terminal disease

Design outcomes

Primary

MeasureTime frame
Muscle strengthup to 2.5 years

Secondary

MeasureTime frameDescription
Duration of hospital stayup to 2.5 years
Functional abilityup to 2.5 yearsFunctional ability will be assessed with the FIM score
Quality of lifeup to 2.5 years

Other

MeasureTime frameDescription
Muscle strength in patients with ICU acquired weakness (ICUAW) at ICU dischargeup to 2.5 yearsIn the subgroup of patients diagnosed with ICUAW improvement in muscle strength will be assessed in patients of the NEMS group as compared to the sham-NEMS group

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026